Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
11/2013
11/12/2013US8580768 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
11/12/2013CA2627365C Process for the production of carboxanilides
11/12/2013CA2565184C Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/07/2013US20130296369 Cyanoenamines and their use as fungicides
11/07/2013US20130296355 Glucagon receptor modulators
11/07/2013US20130296332 1h-quinazoline-2,4-diones
11/07/2013US20130296321 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
11/07/2013US20130296281 Aryl Substituted Indoles and Their Use as Blockers of Sodium Channels
11/06/2013EP2423198B1 Charge controlling agaent containing a monoazo iron complex compound
11/06/2013CN103384662A Novel 1,2-bis-sulfonamide derivatives as chemokine receptor modulators
11/06/2013CN103384661A Mineralocorticoid receptor antagonists
11/06/2013CN102351793B Direct synthesis method of 4-[3-(4- methylphenyl)-5-(trifluoromethyl)-1-hydrogen-pyrazole-1-yl] benzene sulfonamide
11/06/2013CN102065690B Herbicidally effective 4-(3-alkyl sulfinyl benzoyl) pyrazoles
11/06/2013CN101965337B Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
11/06/2013CN101010302B Sigma receptor inhibitors
11/05/2013US8575362 Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
10/2013
10/31/2013WO2013162469A1 Tubulin inhibitors
10/31/2013WO2013159224A1 2-carbamo(thio)yl-1,3- dioxopropyl derivatives in cancer therapy
10/31/2013WO2013121334A3 Agents for treating neurodegenerative disorders
10/31/2013US20130289283 Fipronil production process
10/31/2013US20130289280 Novel pharmaceutical forms, and methods of making and using the same
10/31/2013US20130289025 Pyrazole-substituted arylamides as p2x3 and p2x2/3 antagonists
10/31/2013US20130289004 Anti-staphylococcal celecoxib derivatives
10/30/2013EP2657228A1 Pyrazole synthesis by the coupling of carboxylic acid derivatives and enamines
10/30/2013EP2655333A1 Aminoindanes amides having a high fungicidal activity and their phytosanitary compositions
10/30/2013EP2654748A1 Indazole derivatives useful as erk inhibitors
10/30/2013CN103373989A Preparation method of intermediate of pazopanib hydrochloride
10/30/2013CN103373963A Intermediate of pazopanib hydrochloride and preparation method of intermediate of pazopanib hydrochloride
10/30/2013CN103373962A Method for preparing celecoxib III crystal form
10/30/2013CN103373961A Preparation of (1, 3-diphenyl-1hydrogen-4-pyrazolyl) methyl benzoic acid serial compounds and applications in treatment of melanoma
10/30/2013CN101061099B High stability diionic liquid salts
10/29/2013US8569512 P2X3 receptor antagonists for treatment of pain
10/29/2013US8569353 Pyrazole compound
10/29/2013US8569297 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
10/24/2013WO2013159094A2 Improved processes for the preparation of 1-aryl-5-alkyl pyrazole compounds
10/24/2013WO2013157955A1 Geranyl geranyl acetone analogs and uses thereof
10/24/2013WO2013157926A1 Geranyl geranyl acetone analogs and uses thereof
10/24/2013WO2013157511A1 Arylaminopyrazole derivative
10/24/2013US20130281710 Processes for the preparation of 1-aryl-5-alkyl pyrazole compounds
10/24/2013US20130281505 Pyrazol-4-yl carboxamide derivatives as microbiocides
10/24/2013US20130281455 Phenylpyri(mi)dinylazoles
10/23/2013EP2651902A2 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
10/23/2013EP2651901A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
10/23/2013EP2651900A1 Neprilysin inhibitors
10/23/2013EP2651896A1 Neprilysin inhibitors
10/23/2013CN103370306A Glucagon receptor modulator
10/23/2013CN103360364A Synthetic method of aromatic cyclo-ethanol
10/23/2013CN103360318A Preparation method of sulfonyl azide compounds
10/23/2013CN103360317A Dicyclo-substituted pyrazolone azo derivatives, as well as preparation method and use thereof
10/23/2013CN103360316A Preparation method of fipronil
10/23/2013CN103360315A Heterocyclic aryloxyacetyl hydrazone derivative and its preparation method and application thereof
10/23/2013CN103360314A New preparation method of tebufenpyrad
10/23/2013CN103360313A 3-fluoroalkyl-1-substituted-pyrazolyl-4-carboxylic acid and preparation method thereof
10/23/2013CN103356636A Theramutein调节剂 Theramutein moderator
10/23/2013CN102372532B Palladium-catalyzed ortho-orientation nitrification method of aza calixarene compounds
10/23/2013CN101796026B Guanidine-containing compounds useful as muscarinic receptor antagonists
10/22/2013US8563748 Process for preparing substituted N-phenylhydroxylamines
10/22/2013US8563747 Processes for the alkylation of pyrazoles
10/22/2013US8563736 Amide derivatives, process for preparation thereof and use thereof as insecticide
10/22/2013US8563730 Pyrazole and fused pyrazole glucokinase activators
10/22/2013US8563723 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists
10/22/2013US8563714 Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
10/22/2013US8563512 Neprilysin inhibitors
10/22/2013CA2587455C Substituted pyrazoles, compositions thereof, and their use as pesticides
10/17/2013WO2013154109A1 Novel 1-substituted indazole derivative
10/17/2013WO2013152683A1 Bicycle substituted pyrazoloneazo derivatives and preparation method and use thereof
10/17/2013WO2013152391A1 Viral polymerase inhibitors
10/17/2013US20130274481 Process for the preparation of 3-haloalkylpyrazoles
10/17/2013US20130274256 Novel inhibitors of bacterial biofilms and related methods
10/17/2013US20130274240 Fluorene compound and pharmaceutical use thereof
10/17/2013US20130274227 3,5-diaminopyrazole kinase inhibitors
10/17/2013US20130274218 Viral polymerase inhibitors
10/16/2013EP2648723A1 Bicyclic pyrazole compounds as allosteric modulators of mglur5 receptors
10/16/2013EP2648714A2 Lysophosphatidic acid receptor antagonists and uses thereof
10/16/2013EP2648511A1 Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
10/16/2013CN103351390A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
10/16/2013CN103351342A Edaravone pharmaceutical co-crystal and preparation method thereof
10/16/2013CN103351341A Organic metal chelate, its preparation method and application
10/16/2013CN103351340A Novel preparation method of tolfenpyrad
10/16/2013CN103351339A 3-fluorinated alkyl-1-substituted pyrazole-4-carboxylic acid and preparation method thereof
10/16/2013CN102206183B EBF ((E)-beta-Farnesene) analogues containing pyrazole-carboxamide, and preparation method and application thereof
10/16/2013CN101784543B Indole and indazole compounds as an inhibitor of cellular necrosis
10/15/2013US8558006 Processes relating to the alkylation of pyrazoles
10/15/2013US8557858 (E)-N-(2-amino-phenyl)-3-{1-[4-(l-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide salts
10/15/2013US8557841 Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/15/2013CA2697256C Cyclopropyl amide derivatives
10/10/2013US20130267704 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
10/10/2013US20130267543 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof
10/10/2013US20130267493 Indole and indazole compounds that activate ampk
10/09/2013EP2647629A1 Pyrazole compound having therapeutic effect on multiple myeloma
10/09/2013CN103347510A Lysophosphatidic acid receptor antagonists and uses thereof
10/08/2013US8552050 Activators of pyruvate kinase M2 and methods of treating disease
10/08/2013US8552049 Pyrazolecarboxamide derivatives and their use as microbiocides
10/08/2013US8551993 Phenoxy acetic acids as PPAR delta activators
10/08/2013CA2542898C Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents
10/03/2013WO2013147117A1 Fused azole derivative
10/03/2013WO2013144087A1 N-cycloalkyl-n-[(cycloalkenylphenyl)methylene]-(thio)carboxamide derivatives
10/03/2013WO2013144086A1 Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives
10/03/2013WO2013114403A8 Substituted 4,5-dihydro-2h-benzo[e]indazole-9-carboxylates for the treatment of diabetes and related disorders
10/03/2013US20130261158 Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 256